文献速递妇科

机器人辅助腹腔镜与传统腹腔镜治疗早期子宫内膜样腺癌的肿瘤学结局比较

Oncologic outcomes of robot-assisted laparoscopy versus conventional laparoscopy for the treatment of apparent early-stage endometrioid adenocarcinoma of the uterus.
PubMed 文献 · Gynecol Oncol · 2023-11-18

本研究回顾性分析了2009年1月1日至2018年1月1日在本院接受初次手术的1728例临床局限于子宫的子宫内膜样子宫内膜癌患者,其中1389例(80.4%)接受机器人辅助腹腔镜手术,339例(19.6%)接受传统腹腔镜手术。结果显示两组在复发率、5年无进展生存率和5年总生存率上无显著差异,机器人辅助组未观察到不良生存结局。

要点

  • 机器人辅助组手术时间更长(170 vs 152分钟,P < .001),但中转开腹率更低(0.6% vs 4.7%,P < .001)。
  • 两组淋巴结评估比例(93% vs 90%,P = .1)、复发率(9.5% vs 7.4%,P = .3)和5年总生存率(92.5% vs 92.4%,P = .7)无显著差异。
  • 机器人辅助组复发风险(HR = 1.2,95% CI:0.8-1.9,P = .3)和总生存风险(HR = 0.9,95% CI:0.6-1.4,P = .7)均未显著增加。

核心结论

  • 对于局限于子宫的子宫内膜样子宫内膜癌,机器人辅助腹腔镜手术分期与传统腹腔镜相比未观察到不良生存结局。

研究设计与样本

  • 回顾性病历审查,纳入2009年1月1日至2018年1月1日在本院接受初次手术的新诊断子宫局限性子宫内膜样子宫内膜癌患者,共1728例,其中机器人辅助组1389例(80.4%),传统腹腔镜组339例(19.6%)。

主要发现

  • 机器人辅助组手术时间更长(170 vs 152分钟,P < .001),中转开腹率更低(0.6% vs 4.7%,P < .001)。
  • 机器人辅助组BMI > 40 kg/m2比例更高(17.2% vs 11.5%,P = .01),同日出院比例更高(19.2% vs 5.3%,P < .001)。
  • 两组淋巴结评估比例(93% vs 90%,P = .1)、最终手术病理分期(P = .6)、中位随访时间(55.7 vs 52.9个月,P = .4)、围手术期并发症率(9.9% vs 7.7%,P = .6)、复发率(9.5% vs 7.4%,P = .3)、5年无进展生存率(88.5% vs 91.0%,P = .3)和5年总生存率(92.5% vs 92.4%,P = .7)均无显著差异。
  • 机器人辅助组复发风险(HR = 1.2,95% CI:0.8-1.9,P = .3)和总生存风险(HR = 0.9,95% CI:0.6-1.4,P = .7)均未显著增加。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To compare long-term oncologic outcomes in patients with clinically uterine-confined endometrioid endometrial cancer who underwent surgical staging with robot-assisted (RA) versus conventional laparoscopy. METHODS: We performed a retrospective chart review of patients with newly diagnosed, uterine-confined endometrioid endometrial cancer who were treated and had primary surgery at our institution between 1/1/2009-1/1/2018. Clinicopathologic, surgical, and survival data were collected. Appropriate statistical methods were applied. RESULTS: Of 1728 patients identified, 1389 (80.4%) underwent RA and 339 (19.6%) conventional laparoscopy. At diagnosis, median age was 60 years (range, 24-92) and median BMI was 30.2 kg/m2 (range, 15.1-71.5). In the RA group, patients had longer operative time (170 vs 152 min, P < .001), lower conversion rate to laparotomy (0.6% vs 4.7%, P < .001), and a higher proportion had a BMI > 40 kg/m2 (17.2% vs 11.5%, P = .01) and same-day discharge (19.2% vs 5.3%, P < .001). Overall, 93% (RA) and 90% (conventional) of patients underwent lymph node assessment (P = .1). Comparing the RA versus conventional groups, final surgical stage on pathology (P = .6), median follow-up (55.7 vs 52.9 months, P = .4), and rates of perioperative complications (9.9% vs 7.7%, P = .6), recurrence (9.5% vs 7.4%, P = .3), 5-year PFS (88.5% vs 91.0%, P = .3), and 5-year OS (92.5% vs 92.4%, P = .7) were not significantly different. No significant increase in risk of recurrence (HR = 1.2, 95% CI: 0.8-1.9, P = .3) or poorer OS outcomes (HR = 0.9, 95% CI: 0.6-1.4, P = .7) were observed in the RA group. CONCLUSION: In uterine-confined endometrioid endometrial cancers, surgical staging using RA laparoscopy was not associated with adverse survival outcomes compared to conventional laparoscopy.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Lim YH, Dagher C, Abu-Rustum NR, et al. Oncologic outcomes of robot-assisted laparoscopy versus conventional laparoscopy for the treatment of apparent early-stage endometrioid adenocarcinoma of the uterus. Gynecol Oncol. 2023. PMID: 37980770. doi:10.1016/j.ygyno.2023.11.009

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。